Quick Answer
ABBOTT LABORATORIES reported Diluted EPS of $3.72 per share for fiscal year 2025.
ABBOTT LABORATORIES Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $3.72 | -51.3% |
| 2024 | $7.64 | +134.4% |
| 2023 | $3.26 | -16.6% |
| 2022 | $3.91 | -0.8% |
| 2021 | $3.94 | +57.6% |
| 2020 | $2.50 | +21.4% |
| 2019 | $2.06 | +54.9% |
| 2018 | $1.33 | +392.6% |
| 2017 | $0.27 | -71.3% |
| 2016 | $0.94 | -67.8% |
| 2015 | $2.92 | +96.0% |
| 2014 | $1.49 | -8.0% |
| 2013 | $1.62 | -56.5% |
| 2012 | $3.72 | +23.6% |
| 2011 | $3.01 | +1.7% |
| 2010 | $2.96 | -19.8% |
| 2009 | $3.69 | +18.3% |
| 2008 | $3.12 | +35.1% |
| 2007 | $2.31 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.94 | +0.0% | -6.9% |
| June 30, 2025 | $1.01 | +36.5% | +32.9% |
| March 31, 2025 | $0.76 | +8.6% | -19.1% |
| September 30, 2024 | $0.94 | +14.6% | +27.0% |
| June 30, 2024 | $0.74 | -5.1% | +5.7% |
| March 31, 2024 | $0.70 | -6.7% | -14.6% |
| September 30, 2023 | $0.82 | +1.2% | +5.1% |
| June 30, 2023 | $0.78 | -31.6% | +4.0% |
- ABBOTT LABORATORIES showed a decrease of -51.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2007–2025 period, ABBOTT LABORATORIES’s diluted eps has grown by 61.0% (from $2.31 per share to $3.72 per share).
- The most recent figure is from ABBOTT LABORATORIES’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: